Androgen receptor pathway in rats with autosomal dominant polycystic kidney disease.
暂无分享,去创建一个
[1] James P Calvet,et al. Calcium Restriction Allows cAMP Activation of the B-Raf/ERK Pathway, Switching Cells to a cAMP-dependent Growth-stimulated Phenotype* , 2004, Journal of Biological Chemistry.
[2] D. Wallace,et al. Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells. , 2004, Kidney international.
[3] N. Hollenberg. Aldosterone in the development and progression of renal injury. , 2004, Kidney international.
[4] S. Somlo,et al. Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease , 2004, Nature Medicine.
[5] E. Avner,et al. EGF receptor tyrosine kinase inhibition attenuates the development of PKD in Han:SPRD rats. , 2003, Kidney international.
[6] J. Grantham,et al. Lillian Jean Kaplan International Prize for advancement in the understanding of polycystic kidney disease. Understanding polycystic kidney disease: a systems biology approach. , 2003, Kidney international.
[7] Vincent H Gattone,et al. Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist , 2003, Nature Medicine.
[8] J. Pelling,et al. Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys. , 2003, Kidney international.
[9] R. Maser,et al. Renal activation of extracellular signal-regulated kinase in rats with autosomal-dominant polycystic kidney disease. , 2003, Kidney international.
[10] E. Bamgboye. Hemodialysis: management problems in developing countries, with Nigeria as a surrogate. , 2003, Kidney international. Supplement.
[11] R. Iliescu,et al. Abolition of hypertension-induced end-organ damage by androgen receptor blockade in transgenic rats harboring the mouse ren-2 gene. , 2002, Journal of the American Society of Nephrology : JASN.
[12] James P Calvet,et al. Polycystin-1 Activation of c-Jun N-terminal Kinase and AP-1 Is Mediated by Heterotrimeric G Proteins* , 2002, The Journal of Biological Chemistry.
[13] J. Calvet,et al. The genetics and physiology of polycystic kidney disease. , 2001, Seminars in nephrology.
[14] G. Pelletier. Localization of androgen and estrogen receptors in rat and primate tissues. , 2000, Histology and histopathology.
[15] W. Guggino,et al. cAMP regulates cell proliferation and cyst formation in autosomal polycystic kidney disease cells. , 2000, Journal of the American Society of Nephrology : JASN.
[16] S. Nakai,et al. Gender difference in the mean age at the induction of hemodialysis in patients with autosomal dominant polycystic kidney disease. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[17] C. Lynch,et al. Dihydrotestosterone and estrogen regulation of rat brain androgen-receptor immunoreactivity , 2000, Physiology & Behavior.
[18] I. D. Román,et al. Effect of flutamide-induced androgen-receptor blockade on adenylate cyclase activation through G-protein coupled receptors in rat prostate. , 2000, Cellular signalling.
[19] L P Sullivan,et al. cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway. , 2000, Kidney international.
[20] S. Silbiger,et al. Effect of gender on the progression of nondiabetic renal disease: a meta-analysis. , 2000, Journal of the American Society of Nephrology : JASN.
[21] T. Okamoto,et al. The Polycystic Kidney Disease-1 Protein, Polycystin-1, Binds and Activates Heterotrimeric G-Proteinsin Vitro , 1998 .
[22] William E Sweeney,et al. Functional activity of epidermal growth factor receptors in autosomal recessive polycystic kidney disease. , 1998, American journal of physiology. Renal physiology.
[23] N. Gretz,et al. Increased epithelial cell proliferation and abnormal extracellular matrix in rat polycystic kidney disease. , 1998, Journal of the American Society of Nephrology : JASN.
[24] J. Grantham,et al. Mechanisms of progression in autosomal dominant polycystic kidney disease. , 1997, Kidney international. Supplement.
[25] S. Sandhu,et al. Effects of sex hormones on fluid and solute transport in Madin-Darby canine kidney cells. , 1997, Kidney international.
[26] V. Gattone,et al. Gender and the effect of gonadal hormones on the progression of inherited polycystic kidney disease in rats. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[27] X. Estivill,et al. Linkage, clinical features, and prognosis of autosomal dominant polycystic kidney disease types 1 and 2. , 1996, Journal of the American Society of Nephrology : JASN.
[28] A. Evan,et al. Role of obstruction in autosomal dominant polycystic kidney disease in rats. , 1996, Kidney international.
[29] Patricia A. Gabow,et al. PKD2, a Gene for Polycystic Kidney Disease That Encodes an Integral Membrane Protein , 1996, Science.
[30] K. Georgopoulos,et al. A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma , 1995, Cell.
[31] P. Bork,et al. Polycystic kidney disease: The complete structure of the PKD1 gene and its protein , 1995, Cell.
[32] E. Avner,et al. Tyrosine kinase activity of the EGF receptor in murine metanephric organ culture. , 1995, Kidney international.
[33] E. Avner,et al. Epidermal growth factor receptor expression is abnormal in murine polycystic kidney. , 1995, Kidney international.
[34] J. Pestka,et al. Role of gender and strain in vomitoxin-induced dysregulation of IgA production and IgA nephropathy in the mouse. , 1994, Journal of toxicology and environmental health.
[35] J. Stewart. End-stage renal failure appears earlier in men than in women with polycystic kidney disease. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[36] The European Polycystic Kidney Disease Consortium. The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16 , 1994, Cell.
[37] J. Grantham. 1992 Homer Smith Award. Fluid secretion, cellular proliferation, and the pathogenesis of renal epithelial cysts. , 1993, Journal of the American Society of Nephrology : JASN.
[38] Ann M. Johnson,et al. Renal structure and hypertension in autosomal dominant polycystic kidney disease. , 1990, Kidney international.
[39] Sheldon S. Stoffer. Williams Textbook of Endocrinology , 1987 .
[40] The European Polycystic Kidney Disease Consortium. The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16 , 2004, Pediatric Nephrology.
[41] K. Sandberg,et al. Sex and the renin angiotensin system: implications for gender differences in the progression of kidney disease. , 2003, Advances in renal replacement therapy.
[42] B. Palmer. Sexual dysfunction in men and women with chronic kidney disease and end-stage kidney disease. , 2003, Advances in renal replacement therapy.
[43] R. Maser,et al. Developmental expression of urine concentration-associated genes and their altered expression in murine infantile-type polycystic kidney disease. , 1999, Developmental genetics.
[44] T. Okamoto,et al. The polycystic kidney disease-1 protein, polycystin-1, binds and activates heterotrimeric G-proteins in vitro. , 1998, Biochemical and biophysical research communications.